Sunday 12 May 2024

How is India streamlining the pharma sector? | Explained

Why has the drug regulator tweaked norms for exports? Where does India stand as a drugs manufacturer? Does the change follow allegations of sub-standard medicines being exported? Will a centralising authority help, with several important drugs set to go off the patent list?

from Business News, Finance News, Market News, Stock News, BSE, NSE, Nifty | The Hindu

No comments:

Post a Comment